This Article Full Text Full Text (PDF) All Versions of this Article: 48/5/988    most recent 01.HYP.0000243612.02929.dfv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryan, M. J. Articles by Hendrix, S. T. Search for Related Content PubMed PubMed Citation Articles by Ryan, M. J. Articles by Hendrix, S. T. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Lupus Obesity Related Collections Obesity Animal models of human disease Glucose intolerance

(Hypertension. 2006;48:988.)
© 2006 American Heart Association, Inc.

Original Articles

Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus

From the Department of Physiology, University of Mississippi Medical Center, Jackson, Miss.

Correspondence to Michael J. Ryan, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216. E-mail mjryan{at}physiology.umsmed.edu

Accumulating data indicate that metabolic syndrome is an inflammatory condition. Systemic lupus erythematosus (SLE) is an autoimmune disorder associated with nephritis and cardiovascular disease. Evidence suggests that individuals with SLE are at risk for developing insulin resistance; however, this has not been directly examined. Using an established mouse strain with SLE (NZBWF1), we examined whether SLE is associated with increased body weight and fat deposition. Mean arterial pressure was significantly increased (140±4 versus 114±2 mm Hg; n5) in SLE mice by 36 weeks of age compared with control mice (NZW/LacJ). Body weight in SLE mice was higher at each age compared with controls by 12%, 22%, and 34% (n>30). Visceral adipose tissue weight was increased in SLE by 44%, 74%, and 117% at 8, 20, and 36 weeks, respectively (n12). Plasma leptin was increased in SLE mice (8.6±1.0 versus 24.7±2.2 ng/mL; n=5), and renal and adipose tissue exhibited macrophage infiltration. Fasted insulin was higher in SLE mice (0.6±0.1 versus 1.4±0.3 ng/mL; n10), but fasted glucose was not different (94±5 versus 80±9; n9). A glucose tolerance test caused a significantly greater and longer increase in blood glucose from mice with SLE compared with control mice. Food intake was not different between control and SLE mice. However, mice with SLE demonstrated lower levels of nighttime activity than controls. These data show that the NZBWF1 strain may be an important model to study the effects of obesity and insulin resistance on SLE-associated hypertension.

Key Words: SLE • autoimmune • inflammation • insulin • adipose • leptin • glucose

This article has been cited by other articles:

				M. J. Ryan Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1258 - R1267. [Abstract] [Full Text] [PDF]

				M. Venegas-Pont, J. C. Sartori-Valinotti, C. Maric, L. C. Racusen, P. H. Glover, G. R. McLemore Jr., A. V. Jones, J. F. Reckelhoff, and M. J. Ryan Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1282 - R1289. [Abstract] [Full Text] [PDF]

				M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF]

				R. Iliescu, R. Cazan, G. R. McLemore Jr., M. Venegas-Pont, and M. J. Ryan Renal blood flow and dynamic autoregulation in conscious mice Am J Physiol Renal Physiol, September 1, 2008; 295(3): F734 - F740. [Abstract] [Full Text] [PDF]

				A. Perciaccante, A. Fiorentini, and L. Tubani Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus Hypertension, February 1, 2007; 49(2): e12 - e12. [Full Text] [PDF]

				M. J. Ryan Response to Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus Hypertension, February 1, 2007; 49(2): e13 - e13. [Full Text] [PDF]